Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA updates labeling for NALBUPHINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 33
  • 0 comments

Labeling changes approved for HOSPIRA. Active ingredient: NALBUPHINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 36
  • 0 comments

Labeling changes approved for STRIDES PHARMA INTL. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 37
  • 0 comments

Labeling changes approved for PHARMOBEDIENT. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for METHADONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 33
  • 0 comments

Labeling changes approved for HIKMA. Active ingredient: METHADONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 38
  • 0 comments

Labeling changes approved for STRIDES PHARMA INTL. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for NALBUPHINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 31
  • 0 comments

Labeling changes approved for DR REDDYS. Active ingredient: NALBUPHINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 30
  • 0 comments

Labeling changes approved for LGM PHARMA. Active ingredient: ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for METHADONE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 35
  • 0 comments

Labeling changes approved for HIKMA. Active ingredient: METHADONE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for MEPERIDINE HYDROCHLORIDE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 36
  • 0 comments

Labeling changes approved for SUN PHARM INDUSTRIES. Active ingredient: MEPERIDINE HYDROCHLORIDE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 33
  • 0 comments

Labeling changes approved for STRIDES PHARMA INTL. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025

Comment Full text
  • Previous
  • 18
  • 19
  • 20
  • 21
  • 22
  • Next

Search

News categories

  • Technical Exchange News(12095)
  • Event(5387)
  • SEC News(252326)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150684)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin